Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
18.68
-0.35 (-1.84%)
Apr 1, 2025, 3:35 PM EDT - Market open
Oculis Holding AG Revenue
In the year 2024, Oculis Holding AG had annual revenue of 686.00K CHF, down -22.31%. Oculis Holding AG had revenue of 3.00K in the quarter ending December 31, 2024, a decrease of -98.38%.
Revenue (ttm)
686.00K CHF
Revenue Growth
-22.31%
P/S Ratio
1,330.89
Revenue / Employee
14,000 CHF
Employees
49
Market Cap
988.99M USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 686.00K | -197.00K | -22.31% |
Dec 31, 2023 | 883.00K | -29.00K | -3.18% |
Dec 31, 2022 | 912.00K | -48.00K | -5.00% |
Dec 31, 2021 | 960.00K | -33.00K | -3.32% |
Dec 31, 2020 | 993.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OCS News
- 11 hours ago - Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond - GlobeNewsWire
- 11 hours ago - Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond - GlobeNewsWire
- 11 days ago - Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities - GlobeNewsWire
- 17 days ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewsWire
- 20 days ago - Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 27 days ago - Oculis to Present at Upcoming March Investor Conference - GlobeNewsWire
- 6 weeks ago - Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares - GlobeNewsWire
- 7 weeks ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - GlobeNewsWire